Triple
T667625
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | European Directorate for the Quality of Medicines & HealthCare |
E12899
|
entity |
| Predicate | oversees |
P46
|
FINISHED |
| Object |
Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme
The Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme is a regulatory system that certifies the quality and compliance of pharmaceutical substances with European Pharmacopoeia standards, facilitating their use and acceptance across multiple countries.
|
E12899
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme | Statement: [European Directorate for the Quality of Medicines & HealthCare, oversees, Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme Context triple: [European Directorate for the Quality of Medicines & HealthCare, oversees, Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme]
-
A.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
B.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
-
C.
European Directorate for the Quality of Medicines & HealthCare
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
-
D.
Committee for Herbal Medicinal Products
The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
-
E.
Clinical Practices of the University of Pennsylvania
Clinical Practices of the University of Pennsylvania is the faculty practice plan and outpatient clinical arm of Penn Medicine, providing patient care across a wide range of specialties in collaboration with the University of Pennsylvania’s health system.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme Triple: [European Directorate for the Quality of Medicines & HealthCare, oversees, Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme]
Generated description
The Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme is a regulatory system that certifies the quality and compliance of pharmaceutical substances with European Pharmacopoeia standards, facilitating their use and acceptance across multiple countries.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme Target entity description: The Certification of Suitability to the Monographs of the European Pharmacopoeia (CEP) scheme is a regulatory system that certifies the quality and compliance of pharmaceutical substances with European Pharmacopoeia standards, facilitating their use and acceptance across multiple countries.
-
A.
Committee for Proprietary Medicinal Products
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
B.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
-
C.
European Directorate for the Quality of Medicines & HealthCare
chosen
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
-
D.
Committee for Herbal Medicinal Products
The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
-
E.
Clinical Practices of the University of Pennsylvania
Clinical Practices of the University of Pennsylvania is the faculty practice plan and outpatient clinical arm of Penn Medicine, providing patient care across a wide range of specialties in collaboration with the University of Pennsylvania’s health system.
- F. None of above.
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a493355dec819098d4244b2fa34885 |
completed | March 1, 2026, 7:27 p.m. |
| NER | Named-entity recognition | batch_69a49ff7ca788190bef58ce46849b9d0 |
completed | March 1, 2026, 8:22 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69a5c39d11508190a3bd0f118d122e1a |
completed | March 2, 2026, 5:06 p.m. |
| NEDg | Description generation | batch_69a5c486463c8190905f9b0cbc0ba053 |
completed | March 2, 2026, 5:10 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69a5ce6be0b081909067962eef2ba7a2 |
completed | March 2, 2026, 5:52 p.m. |
Created at: March 1, 2026, 7:36 p.m.